Main > A1. CORP. INDEX. B-Bm > BioCryst Pharmaceuticals/P C2

---

BioCryst Pharmaceuticals/P C2's subsections
2010. 09.15.2010. Onco.>CTCL
2010. 12.04.2010. Onco.>CLL
2011. 03.09.2011. Financing
2011. 05.25.2011. CFO
2011. 06.27.2011. BoD
2012. 01.19.2012. Board Directors
2012. 02.15.2012. Hepato.>HCV
2012. 07.24.2012. Gout
2012. 11.12.2012. Yellow Fever
2012. 11.30.2012. Presidio
2012. 12.07.2012. ReStructuring
2014. 08.29. Ebola
2014. 12.22. Influenza>Peramivir
2015. 03.31. Ebola BARDA Contract
2017. 01.08. Influenza>Peramivir
2020. 12.03. Hemato.>HAE>USA>OK
2020. 12.16. Hemato.>HAE>USA>Launch
2021. 01.22. Hemato.>HAE>JP>OK
2021. 02.03. Influenza>Peramivir
2022. 06.06. Hemato.>HAE>CA>OK
2022. 06.07. Hemato.>HAE>CH>OK
2022. 08.18. Hemato.>HAE>SA>OK
2022. 11.28. Hemato.>HAE>IL>OK
2023. 05.22. Hemato.>HAE>CL>OK
2024. 02.19. Hemato.>HAE>IT>Launch
Patents
Web-Site
Z - OK

BioCryst Pharmaceuticals/P C2's products
This section has no products